Doug Thiede

innovative ideas...MT @dsgold: Congrats to @neurotrack 4 winning health #sxaccelerator #SXSW contenders @docphin @careporthealth

Congrats to @SanofiUS RT @pharmaphorum: FDA approves antisense cholesterol drug pharmaphorum.com/forums/topi… #pharma #cardiovascular #antisense

Intreresting take on agencies.... Why Advertising Agencies Must Disrupt Themselves | LinkedIn linkedin.com/today/post/arti…

Congrats to these campaigns MT @HavasLifeMET: 4 innovative campaigns that pushed pharma social media forward: medcitynews.com/2012/06/4-in… #HCSM

RT @cafepharma: Forest Labs submits potential antipsychotic treatment cariprazine for FDA review: Yahoo/AP Wed,11/28/12 dlvr.it/2YJSkS

Worthy point MT @rofidalchris: RT @lukehellier: Cantor- device tax repeal should be part of fiscal cliff discussion j.mp/TrU4Nl

staggering #s! RT @tedokoncoa: More than 1M cancer survivors skipping #cancer care because of cost, according to AACR. ow.ly/fzGTZ

Upbeat news out of the Dx industry from @markhfierce and @evaluatemedtech bit.ly/TiJZ2B

Interesting vc bet on 2 big markets RT @johncfierce: Pfizer gets Rhythm with $8M bet on diabetes, obesity drug work - fiercebiotech.com/story/pfiz…

RT @fiercebiotech: Sanofi's new CSO to steer R&D reinvention drive from Cambridge, MA office bit.ly/TGkarO $SNY #biotech #pharma

Good summary RT @medicaldevices: As George Will wrote, #MedDeviceTax will "Tax Jobs out of Existence" tiny.cc/mwtrnw #RepealDeviceTax

Summary of the stent market from @markhfierce: bit.ly/TurFEK @rofidalchris

RT @fiercemeddev: As advocates fight to #repealdevicetax, we take a detailed look at how the 2.3% charge would work. ow.ly/fjwZF

Congrats! @FierceBiotech: Anne Wojcicki - Women in #Biotech 2012 bit.ly/SwOiHb @23andMe